Further studies are warranted in order to determine whether in treatment naïve patients the small proportion of recently emigrant CLL cells that overexpress MCL-1 and BCL-XL also express high levels of SPHK2. Here, SPHK2 is linked to B-cell chronic lymphocytic leukemia.